Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome

The aim of the study was to assess hypocaloric diet effects on platelet aggregation and their mechanisms in patients with arterial hypertension (AH), android obesity (AO), and impaired glucose tolerance (IGT). In total, 25 middle;aged patients with AH, AO and IGT were examined. Anthropometry, assess...

Full description

Bibliographic Details
Main Author: I. N. Medvedev
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC  2006-02-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/1694
id doaj-8a717796ec284130b7f05fbc29751a60
record_format Article
spelling doaj-8a717796ec284130b7f05fbc29751a602021-07-28T14:02:08Zrus«FIRMA «SILICEA» LLC Российский кардиологический журнал1560-40712618-76202006-02-010127321460Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndromeI. N. Medvedev0Курский институт социального образования (филиал) РГСУThe aim of the study was to assess hypocaloric diet effects on platelet aggregation and their mechanisms in patients with arterial hypertension (AH), android obesity (AO), and impaired glucose tolerance (IGT). In total, 25 middle;aged patients with AH, AO and IGT were examined. Anthropometry, assessment of lipid profile, plasma and platelet lipid peroxidation, and platelet hemostasis were performed. All participants received hypocaloric diet for 24 weeks. In patients with AH, AO and IGT, hypocaloric diet improved lipid profile, suppressed peroxidation syndrome, beneficial; ly influenced intra;platelet aggregation mechanisms. Hypocaloric diet also decreased in vitro platelet adhesion and aggrega;tion, especially by the end of 24;week intervention, even though control levels were not achieved. Conclusion. For adequate correction of metabolism and platelet hemostasis in patients with AH, AO and IGT, isolated administration of hypocaloric diet is not enough. Other therapeutic approaches are needed for individuals with AH, AO and IGT.https://russjcardiol.elpub.ru/jour/article/view/1694arterial hypertensionabdominal obesityimpaired glucose toleranceplateletshypocaloric diet
collection DOAJ
language Russian
format Article
sources DOAJ
author I. N. Medvedev
spellingShingle I. N. Medvedev
Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
Российский кардиологический журнал
arterial hypertension
abdominal obesity
impaired glucose tolerance
platelets
hypocaloric diet
author_facet I. N. Medvedev
author_sort I. N. Medvedev
title Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
title_short Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
title_full Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
title_fullStr Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
title_full_unstemmed Hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
title_sort hypocaloric diet in thrombosis risk reduction among patients with arterial hypertension and metabolic syndrome
publisher «FIRMA «SILICEA» LLC 
series Российский кардиологический журнал
issn 1560-4071
2618-7620
publishDate 2006-02-01
description The aim of the study was to assess hypocaloric diet effects on platelet aggregation and their mechanisms in patients with arterial hypertension (AH), android obesity (AO), and impaired glucose tolerance (IGT). In total, 25 middle;aged patients with AH, AO and IGT were examined. Anthropometry, assessment of lipid profile, plasma and platelet lipid peroxidation, and platelet hemostasis were performed. All participants received hypocaloric diet for 24 weeks. In patients with AH, AO and IGT, hypocaloric diet improved lipid profile, suppressed peroxidation syndrome, beneficial; ly influenced intra;platelet aggregation mechanisms. Hypocaloric diet also decreased in vitro platelet adhesion and aggrega;tion, especially by the end of 24;week intervention, even though control levels were not achieved. Conclusion. For adequate correction of metabolism and platelet hemostasis in patients with AH, AO and IGT, isolated administration of hypocaloric diet is not enough. Other therapeutic approaches are needed for individuals with AH, AO and IGT.
topic arterial hypertension
abdominal obesity
impaired glucose tolerance
platelets
hypocaloric diet
url https://russjcardiol.elpub.ru/jour/article/view/1694
work_keys_str_mv AT inmedvedev hypocaloricdietinthrombosisriskreductionamongpatientswitharterialhypertensionandmetabolicsyndrome
_version_ 1721269668998545408